Treatment Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

What are the effects of radical prostatectomy without pelvic lymph node dissection in prostate cancer?

Posted by on Nov 29, 2019 in Prostate cancer | 0 comments

In a nutshell This study investigated the outcomes of radical prostatectomy (RP) without pelvic lymph node dissection (PLND) in patients with prostate cancer. The main finding was that 5 years after treatment, 100% of patients at low risk for cancer recurrence had survived. Some background PLND is surgery to remove the lymph nodes from the pelvis....

Read More

Evaluating the risk of lung side effects in older patients with Hodgkin lymphoma

Posted by on Nov 29, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated whether older patients with Hodgkin lymphoma (HL) were at high risk for developing lung side effects when treated with bleomycin (Blenoxane). The authors found that the odds of developing lung side effects increased significantly with age in these patients. Some background For patients with HL, age is one of...

Read More

Comparing the safety and effectiveness of peficitinib doses in patients with rheumatoid arthritis

Posted by on Nov 29, 2019 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated the safety and effectiveness of different doses of peficitinib (Smyraf; PFC) in treating rheumatoid arthritis (RA). They found that PFC doses of 50 mg or higher were the most effective in these patients. Some background Rheumatoid arthritis (RA) is a chronic condition caused by inflammation....

Read More

High-frequency repetitive transcranial magnetic stimulation improves freezing of gait in patients with Parkinson’s disease

Posted by on Nov 29, 2019 in Parkinson's Disease | 0 comments

In a nutshell This study investigated the effectiveness of high frequency repetitive transcranial magnetic stimulation (HFMS) in patients with Parkinson's disease (PD). Researchers suggested that HFMS improves freezing of gait (FOG) in these patients. Some background Parkinson's disease (PD) affects brain cells. The abilities controlled by...

Read More

Evaluating immune-related side effects associated with pembrolizumab.

Posted by on Nov 29, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out what put patients at risk of having immune-related side effects when they were treated with pembrolizumab (Keytruda). The study found that patients with a higher body mass index (BMI; a measurement of weight in relation to height) and more cycles of treatment were more likely to determine immune-related side...

Read More

Evaluating immune-related side effects associated with pembrolizumab.

Posted by on Nov 29, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study wanted to find out what put patients at risk of having immune-related side effects when they were treated with pembrolizumab (Keytruda). The study found that patients with a higher body mass index (BMI; a measurement of weight in relation to height) and more cycles of treatment were more likely to determine immune-related side...

Read More

Evaluating immune-related side effects associated with pembrolizumab.

Posted by on Nov 29, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study wanted to find out what put patients at risk of having immune-related side effects when they were treated with pembrolizumab (Keytruda). The study found that patients with a higher body mass index (BMI; a measurement of weight in relation to height) and more cycles of treatment were more likely to determine immune-related side...

Read More

What are the effects of salvage stereotactic radiotherapy (SSRT) in prostate cancer relapse after prostate surgery?

Posted by on Nov 28, 2019 in Prostate cancer | 0 comments

In a nutshell This study investigated the effects of salvage stereotactic radiotherapy (SSRT) in patients with prostate bed recurrence after prostate surgery. The main finding was that SSRT was effective at curing or delaying prostate cancer recurrence. Some background Almost 30% of men who undergo radical prostatectomy (complete removal of the...

Read More